KIF1A.ORG is a global community dedicated to improving the lives of those affected by KIF1A Associated Neurological Disorder and accelerating research to find a cure. KAND is a neurodegenerative disorder caused by mutations in the KIF1A gene and causes a constellation of medical challenges, including spastic paraplegia, epilepsy, intellectual disability, optic nerve atrophy, cerebellar atrophy, peripheral neuropathy, and autism. KAND is a pediatric-onset disorder with a progressive course and can cause severe, life-threatening complications. In addition to family support and patient advocacy, KIF1A.ORG powers collaborative and translational research to rapidly discover treatment for this generation of KAND patients. KIF1A.ORG manages several programs to de-risk and accelerate therapeutic development, including the KIF1A Research Network, direct research funding and open access tools for development, such as natural history data, disease models, biomarkers and outcome measures. For more information, visit www.kif1a.org.
top of page
Disclaimer: The information contained in this page is provided by the partnering patient organization for informational purposes only. The 40 Percent Inc. does not warrant its completeness or accuracy, and it should not be construed as an endorsement by The 40 Percent Inc. or relied upon as a basis for your support for the partnering patient organization. The information is subject to change without notice.
bottom of page